BREAKING NEWS: India Bank Futures Return to Premium Amid Rate Cut Speculation

Bloomberg - Home Search
Celgene Corp (CELG:US)
update May 28
114.93 -1.09 (-0.94%)
High 116.23
Low 114.35
Open 115.84
Volume 2811742
Time May 28
intra-day chart
High 129.06
Low 75.62
P/E 37.35
Return +50.21%
Mkt Cap 91.156 B
one year chart
Company News
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.